Collection of samples for pyronaridine pharmacology analysis

These guidelines aim to standardize the sample collection procedure during clinical studies of pyronaridine antimalarial drugs

 

 

Publication Version
2.0
Publication Code
CL17
Procedure Author
Chris Lourens

The purpose of this document is to standardize the sample collection procedure during clinical studies of pyronaridine antimalarial drugs. This should be considered as a recommendation or as a definition of minimum requirements, created by WWARN, aiming to achieve homogeneous quality in the pre-analytical phase of studies and to provide guidelines in the processes of collection, processing, preserving, storage, shipment and safe handling of samples from human origin.